SARS-CoV-2 Omicron spike glycoprotein receptor binding domain exhibits super-binder ability with ACE2 but not convalescent monoclonal antibody-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SARS-CoV-2 Omicron spike glycoprotein receptor binding domain exhibits super-binder ability with ACE2 but not convalescent monoclonal antibody

Published:2022-03 Issue: Volume:142 Page:105226
ISSN:0010-4825
Container-title:Computers in Biology and Medicine
language:en
Short-container-title:Computers in Biology and Medicine

Author:

Omotuyi Olaposi,Olubiyi Olujide,Nash Oyekanmi,Afolabi Elizabeth,Oyinloye Babatunji,Fatumo Segun,Femi-Oyewo Mbang,Bogoro Suleiman

Publisher

Elsevier BV

Subject

Health Informatics,Computer Science Applications

Reference33 articles.

1. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor;Hoffmann;Cell,2020

2. Structural stability of the SARS-CoV-2 main protease: can metal ions affect function?;Kozak;J. Inorg. Biochem.,2020

3. Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins;Li;Cell Rep.,2021

4. An exclusive 42 amino acid signature in pp1ab protein provides insights into the evolutive history of the 2019 novel human-pathogenic coronavirus (SARS-CoV-2);Cardenas-Conejo;J. Med. Virol.,2020

5. A novel cell culture system modeling the SARS-CoV-2 life cycle;Ju;PLoS Pathog.,2021

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Profiling of linear B-cell epitopes against human coronaviruses in pooled sera sampled early in the COVID-19 pandemic;2024-03-01

2. SARS-CoV-2 Omicron Spike shows strong binding affinity and favourable interaction landscape with the TLR4/MD2 compared to other variants;Journal of Genetic Engineering and Biotechnology;2024-03

3. Evolution of SARS-COV-2;Genetics and Evolution of Infectious Diseases;2024

4. Computational design of novel nanobodies targeting the receptor binding domain of variants of concern of SARS-CoV-2;PLOS ONE;2023-10-24

5. Anti-viral Application of Ganoderma Lucidum in COVID-19;Current Traditional Medicine;2023-06-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3